Therapeutic potential of senolytic agent quercetin in osteoarthritis: A systematic review and meta-analysis of preclinical studies
Ageing Research Reviews · 2023-09 · 90 · 101989
DOI: 10.1016/j.arr.2023.101989 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Ageing Research Reviews, 2023-09. Verfasst von Kohei Yamaura und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA; Department of Orthopaedic Surgery, Kobe Univ…. Hauptthemen laut MEDLINE: Osteoarthritis, Osteoarthritis, Knee. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Quercetin, a natural flavonoid, has shown promise as a senolytic agent for various degenerative diseases. Recently, its protective effect against osteoarthritis (OA), a representative age-related disease of the musculoskeletal system, has attracted much attention. The aim of this study is to summarize and analyze the current literature on the effects of quercetin on OA cartilage in in vivo preclinical studies. METHODS: The Medline (via/using PubMed), Embase, and Web of Science databases were searched up to March 10th, 2023. Risk of bias and the qualitative assessment including mechanisms of all eligible studies and a meta-analysis of cartilage histological scores among the applicable studies was performed. RESULTS: A total of 12 in vivo animal studies were included in this systematic review. A random-effects meta-analysis was performed on six studies using the Osteoarthritis Research Society International (OARSI) scoring system, revealing that quercetin significantly improved OA cartilage OARSI scores (SMD, -6.30 [95% CI, -9.59 to -3.01]; P = 0.0002; heterogeneity: I2 = 86%). The remaining six studies all supported quercetin's protective effects against OA during disease and aging. CONCLUSIONS: Quercetin has shown beneficial effects on cartilage during OA across animal species. Future double-blind randomized controlled clinical trials are needed to verify the efficacy of quercetin in the treatment of OA in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA; Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
- Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA.
- Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA; Department of Orthopaedic Surgery, University Hospital of Occupational and Environmental Health, Fukuoka, Japan.
- Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA; The Orthopaedic Trauma Institute, University of California, San Francisco (UCSF), San Francisco, CA, USA.
- Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA; The Steadman Clinic, Vail, CO, USA.
- Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA. Electronic address: jhuard@sprivail.org.
Zitieren
APA
Yamaura, K., Nelson, A. L., Nishimura, H., Rutledge, J. C., Ravuri, S. K., Bahney, C., Philippon, M. J., & Huard, J. (2023). Therapeutic potential of senolytic agent quercetin in osteoarthritis: A systematic review and meta-analysis of preclinical studies. Ageing Research Reviews, 90, 101989. https://doi.org/10.1016/j.arr.2023.101989
Vancouver
Yamaura K, Nelson AL, Nishimura H, Rutledge JC, Ravuri SK, Bahney C, et al. Therapeutic potential of senolytic agent quercetin in osteoarthritis: A systematic review and meta-analysis of preclinical studies. Ageing Research Reviews. 2023;90:101989. doi:10.1016/j.arr.2023.101989
BibTeX
@article{Yamaura2023,
author = {Yamaura, Kohei and Nelson, Anna Laura and Nishimura, Haruki and Rutledge, Joan C and Ravuri, Sudheer K and Bahney, Chelsea and Philippon, Marc J and Huard, Johnny},
title = {Therapeutic potential of senolytic agent quercetin in osteoarthritis: A systematic review and meta-analysis of preclinical studies},
journal = {Ageing Research Reviews},
year = {2023},
volume = {90},
pages = {101989},
doi = {10.1016/j.arr.2023.101989}
}
EUVIMED